BIM-EL localization: The key to understanding anoikis resistance in inflammatory breast cancer cells

Inflammatory breast cancer (IBC) is a highly metastatic and rare type of breast cancer, accounting for 2–6% of newly diagnosed breast cancer cases each year. The highly metastatic nature of IBC cells remains poorly understood. Here we describe our recent data regarding the ability of IBC cells to ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchheit, Cassandra L, Schafer, Zachary T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845165/
https://www.ncbi.nlm.nih.gov/pubmed/27308529
http://dx.doi.org/10.1080/23723556.2015.1011474
Descripción
Sumario:Inflammatory breast cancer (IBC) is a highly metastatic and rare type of breast cancer, accounting for 2–6% of newly diagnosed breast cancer cases each year. The highly metastatic nature of IBC cells remains poorly understood. Here we describe our recent data regarding the ability of IBC cells to overcome anoikis.

Ejemplares similares